BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 4155933)

  • 1. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of hydralazine-beta blockader association in hypertension of pregnancy].
    Monnier JC; Honore P; Lanciaux B; Boulogne M
    Lille Med; 1978; 23(9):660-6. PubMed ID: 32453
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of combined treatment with hydrochlorothiazide and oxprenolol on arterial pressure and activity of plasma renin. Preliminary results].
    Gysling E; de Wurstemberger B
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1797-8. PubMed ID: 4456598
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.
    Zacest R; Gilmore E; Koch-Weser J
    N Engl J Med; 1972 Mar; 286(12):617-22. PubMed ID: 4401216
    [No Abstract]   [Full Text] [Related]  

  • 6. Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.
    Glazer N
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):561-72. PubMed ID: 4628678
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 8. [An example of an acceptable combination in the treatment of arterial hypertension].
    Menard J; Plouin PF; Gouin F; Corvol P; Milliez P
    Sem Hop; 1978 Feb; 54(4):201-6. PubMed ID: 208167
    [No Abstract]   [Full Text] [Related]  

  • 9. [Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension].
    Löllgen H; Schmidt A; Upmeyer HJ
    Med Klin (Munich); 1986 Nov; 81(23):745-50. PubMed ID: 2880283
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
    Paran E; Holzberg G; Mazor M; Zmora E; Insler V
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oxprenolol in the treatment of essential arterial hypertension].
    Soto Rojas G
    Prensa Med Mex; 1976; 41(5-6):188-93. PubMed ID: 792867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihypertensive effect of the association of a beta adrenergic blockader, a vasodilator and a diuretic in slightly uremic hypertensive patients].
    Actis E; Amato EA; Palmero HA; Rebora EH; Fernández Vidal JM
    Medicina (B Aires); 1978; 38(6 Pt 1):673-8. PubMed ID: 750859
    [No Abstract]   [Full Text] [Related]  

  • 13. Nepresol in the treatment of hypertension of major severity.
    Németh M; Tényi I; Pár A
    Acta Med Acad Sci Hung; 1979; 36(1):105-17. PubMed ID: 393042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hypertension with large doses of the beta-adrenergic blocking drug oxprenolol, alone, and in combination with the vasodilator dihydralazine.
    Tuckman J; Messerli F; Hodler J
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():159s-61. PubMed ID: 4593561
    [No Abstract]   [Full Text] [Related]  

  • 16. [Slow-release hydralazine in the treatment of essential arterial hypertension].
    Moscovici H; Yasbeck Júnior P; Fadul Neto J
    Arq Bras Cardiol; 1982 Sep; 39(3):197-9. PubMed ID: 7186366
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 18. Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.
    van Brummelen P; Bühler FR; Kiowski W; Bolli P; Bertel O
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):380-5. PubMed ID: 40887
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
    Ocón J; Oliván J; Garrido Peralta M; Ruilope L; Rodicio JL; Seco Vasco J; Rodríguez Alvarez J; Gras X
    Med Clin (Barc); 1985 Nov; 85(15):617-21. PubMed ID: 3908851
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ergometric studies for supplementary evaluation of antihypertensive therapy].
    Franz IW; Lohmann FW
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():325-7. PubMed ID: 347807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.